

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 5.10385500 |
| 2 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.09821906 |
| 3 | intestinal epithelial cell development (GO:0060576) | 5.09237039 |
| 4 | regulation of gene silencing by RNA (GO:0060966) | 4.75382726 |
| 5 | regulation of posttranscriptional gene silencing (GO:0060147) | 4.75382726 |
| 6 | regulation of gene silencing by miRNA (GO:0060964) | 4.75382726 |
| 7 | regulation of hippo signaling (GO:0035330) | 4.63492553 |
| 8 | semaphorin-plexin signaling pathway (GO:0071526) | 4.50849625 |
| 9 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.41990795 |
| 10 | lung epithelium development (GO:0060428) | 4.35958762 |
| 11 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.33932244 |
| 12 | intestinal cholesterol absorption (GO:0030299) | 4.11835915 |
| 13 | GDP-mannose metabolic process (GO:0019673) | 4.11460249 |
| 14 | positive regulation of keratinocyte differentiation (GO:0045618) | 4.06861490 |
| 15 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 4.06250930 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 4.04868679 |
| 17 | proline biosynthetic process (GO:0006561) | 4.04451007 |
| 18 | trophectodermal cell differentiation (GO:0001829) | 4.03419672 |
| 19 | establishment of apical/basal cell polarity (GO:0035089) | 3.99770576 |
| 20 | epithelial structure maintenance (GO:0010669) | 3.99252179 |
| 21 | regulation of female receptivity (GO:0045924) | 3.97035786 |
| 22 | phosphate ion homeostasis (GO:0055062) | 3.93915802 |
| 23 | trivalent inorganic anion homeostasis (GO:0072506) | 3.93915802 |
| 24 | regulation of water loss via skin (GO:0033561) | 3.93460550 |
| 25 | negative regulation of cell size (GO:0045792) | 3.91082751 |
| 26 | response to food (GO:0032094) | 3.90279372 |
| 27 | ear development (GO:0043583) | 3.88062539 |
| 28 | regulation of cholesterol homeostasis (GO:2000188) | 3.87167459 |
| 29 | regulation of extracellular matrix disassembly (GO:0010715) | 3.81368544 |
| 30 | multicellular organismal water homeostasis (GO:0050891) | 3.72579647 |
| 31 | intestinal absorption (GO:0050892) | 3.68264490 |
| 32 | primary alcohol catabolic process (GO:0034310) | 3.67776765 |
| 33 | cysteine metabolic process (GO:0006534) | 3.62437364 |
| 34 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.61363278 |
| 35 | folic acid metabolic process (GO:0046655) | 3.61357022 |
| 36 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.60235558 |
| 37 | female mating behavior (GO:0060180) | 3.50377660 |
| 38 | activation of Rac GTPase activity (GO:0032863) | 3.50107962 |
| 39 | COPI coating of Golgi vesicle (GO:0048205) | 3.49073427 |
| 40 | Golgi transport vesicle coating (GO:0048200) | 3.49073427 |
| 41 | proline metabolic process (GO:0006560) | 3.45838813 |
| 42 | ethanol metabolic process (GO:0006067) | 3.45471580 |
| 43 | striated muscle atrophy (GO:0014891) | 3.44326496 |
| 44 | vitamin transmembrane transport (GO:0035461) | 3.43837157 |
| 45 | interferon-gamma secretion (GO:0072643) | 3.42922884 |
| 46 | regulation of translational fidelity (GO:0006450) | 3.39214113 |
| 47 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.36595493 |
| 48 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.33478364 |
| 49 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.31372861 |
| 50 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.28887482 |
| 51 | glycine metabolic process (GO:0006544) | 3.28165131 |
| 52 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.28093276 |
| 53 | serine family amino acid catabolic process (GO:0009071) | 3.27740494 |
| 54 | anterior/posterior axis specification, embryo (GO:0008595) | 3.27282037 |
| 55 | amyloid precursor protein catabolic process (GO:0042987) | 3.26396509 |
| 56 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.23204050 |
| 57 | L-phenylalanine metabolic process (GO:0006558) | 3.23204050 |
| 58 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.22766068 |
| 59 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.21515305 |
| 60 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.20889737 |
| 61 | polarized epithelial cell differentiation (GO:0030859) | 3.18462644 |
| 62 | glucose 6-phosphate metabolic process (GO:0051156) | 3.17280757 |
| 63 | establishment of monopolar cell polarity (GO:0061162) | 3.16851571 |
| 64 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.16851571 |
| 65 | regulation of cholesterol metabolic process (GO:0090181) | 3.16803165 |
| 66 | establishment of skin barrier (GO:0061436) | 3.14898794 |
| 67 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.11045120 |
| 68 | regulation of Cdc42 GTPase activity (GO:0043088) | 3.09053427 |
| 69 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.08798043 |
| 70 | cell-cell junction maintenance (GO:0045217) | 3.07970643 |
| 71 | glutathione biosynthetic process (GO:0006750) | 3.06126223 |
| 72 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.05132545 |
| 73 | lysine catabolic process (GO:0006554) | 3.04625254 |
| 74 | lysine metabolic process (GO:0006553) | 3.04625254 |
| 75 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.04580342 |
| 76 | 4-hydroxyproline metabolic process (GO:0019471) | 3.03881805 |
| 77 | protein retention in ER lumen (GO:0006621) | 3.03224338 |
| 78 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.02945536 |
| 79 | serine family amino acid metabolic process (GO:0009069) | 3.02217053 |
| 80 | amyloid precursor protein metabolic process (GO:0042982) | 3.00497904 |
| 81 | nitric oxide biosynthetic process (GO:0006809) | 3.00422922 |
| 82 | paraxial mesoderm development (GO:0048339) | 3.00399737 |
| 83 | urea cycle (GO:0000050) | 2.99274520 |
| 84 | heterochromatin organization (GO:0070828) | 2.98480506 |
| 85 | establishment of epithelial cell polarity (GO:0090162) | 2.97976187 |
| 86 | negative regulation of viral release from host cell (GO:1902187) | 2.97697142 |
| 87 | O-glycan processing (GO:0016266) | 2.97433365 |
| 88 | homocysteine metabolic process (GO:0050667) | 2.97083421 |
| 89 | COPII vesicle coating (GO:0048208) | 2.96314349 |
| 90 | sulfate transmembrane transport (GO:1902358) | 2.96187212 |
| 91 | skeletal muscle adaptation (GO:0043501) | 2.95276496 |
| 92 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.94908928 |
| 93 | flavonoid metabolic process (GO:0009812) | 2.93995964 |
| 94 | water homeostasis (GO:0030104) | 2.93880232 |
| 95 | positive regulation of histone deacetylation (GO:0031065) | 2.89485872 |
| 96 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.86466763 |
| 97 | L-phenylalanine catabolic process (GO:0006559) | 2.86466763 |
| 98 | mannose metabolic process (GO:0006013) | 2.85676135 |
| 99 | tetrahydrofolate metabolic process (GO:0046653) | 2.84919242 |
| 100 | regulation of viral release from host cell (GO:1902186) | 2.83092990 |
| 101 | urea metabolic process (GO:0019627) | 2.82944698 |
| 102 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.81991456 |
| 103 | muscle atrophy (GO:0014889) | 2.80345570 |
| 104 | epithelial cell-cell adhesion (GO:0090136) | 2.79030465 |
| 105 | hepatocyte apoptotic process (GO:0097284) | 2.78029074 |
| 106 | glyoxylate metabolic process (GO:0046487) | 2.76090932 |
| 107 | cell differentiation involved in embryonic placenta development (GO:0060706) | 2.74503269 |
| 108 | regulation of keratinocyte differentiation (GO:0045616) | 2.74013048 |
| 109 | epoxygenase P450 pathway (GO:0019373) | 2.73718257 |
| 110 | folic acid-containing compound metabolic process (GO:0006760) | 2.73478112 |
| 111 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.72776569 |
| 112 | histone H4-K12 acetylation (GO:0043983) | 2.71960576 |
| 113 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.71777900 |
| 114 | maternal placenta development (GO:0001893) | 2.71267152 |
| 115 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.70991165 |
| 116 | urate metabolic process (GO:0046415) | 2.70584119 |
| 117 | embryonic process involved in female pregnancy (GO:0060136) | 2.70319831 |
| 118 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.69826942 |
| 119 | histone H2A monoubiquitination (GO:0035518) | 2.69822810 |
| 120 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.68827791 |
| 121 | pre-miRNA processing (GO:0031054) | 2.67252275 |
| 122 | serine family amino acid biosynthetic process (GO:0009070) | 2.66335003 |
| 123 | cell junction maintenance (GO:0034331) | 2.65131298 |
| 124 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.65073489 |
| 125 | glucocorticoid biosynthetic process (GO:0006704) | 2.64697073 |
| 126 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.63930145 |
| 127 | nucleobase biosynthetic process (GO:0046112) | 2.63839150 |
| 128 | formation of translation preinitiation complex (GO:0001731) | 2.63730695 |
| 129 | vitamin transport (GO:0051180) | 2.63372351 |
| 130 | regulation of ruffle assembly (GO:1900027) | 2.62933911 |
| 131 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.60567354 |
| 132 | endothelial cell chemotaxis (GO:0035767) | 2.60499046 |
| 133 | L-ascorbic acid metabolic process (GO:0019852) | 2.58893815 |
| 134 | negative regulation of fatty acid transport (GO:2000192) | 2.58362828 |
| 135 | myelin maintenance (GO:0043217) | 2.58269049 |
| 136 | cellular modified amino acid catabolic process (GO:0042219) | 2.57164429 |
| 137 | positive regulation of nuclease activity (GO:0032075) | 2.56939019 |
| 138 | regulation of interleukin-13 production (GO:0032656) | 2.56029184 |
| 139 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.55336740 |
| 140 | stress granule assembly (GO:0034063) | 2.54508990 |
| 141 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.52502913 |
| 142 | nuclear pore organization (GO:0006999) | 2.51860401 |
| 143 | renal filtration (GO:0097205) | 2.51839544 |
| 144 | positive regulation of lipid catabolic process (GO:0050996) | 2.51364323 |
| 145 | phospholipid efflux (GO:0033700) | 2.51303877 |
| 146 | receptor catabolic process (GO:0032801) | 2.49402365 |
| 147 | atrioventricular valve morphogenesis (GO:0003181) | 2.49103100 |
| 148 | modified amino acid transport (GO:0072337) | 2.49043051 |
| 149 | apoptotic process involved in morphogenesis (GO:0060561) | 2.47850084 |
| 150 | regulation of bile acid biosynthetic process (GO:0070857) | 2.46541464 |
| 151 | embryonic placenta development (GO:0001892) | 2.46509283 |
| 152 | purine nucleobase biosynthetic process (GO:0009113) | 2.45930111 |
| 153 | drug transmembrane transport (GO:0006855) | 2.45440985 |
| 154 | drug catabolic process (GO:0042737) | 2.42451211 |
| 155 | hormone catabolic process (GO:0042447) | 2.41028075 |
| 156 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.40507883 |
| 157 | regulation of nuclease activity (GO:0032069) | 2.40441610 |
| 158 | pteridine-containing compound metabolic process (GO:0042558) | 2.40411794 |
| 159 | tricarboxylic acid metabolic process (GO:0072350) | 2.39132920 |
| 160 | mitotic nuclear envelope disassembly (GO:0007077) | 2.39039142 |
| 161 | mitochondrial DNA metabolic process (GO:0032042) | 2.38878269 |
| 162 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.36187778 |
| 163 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.35966982 |
| 164 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.35966982 |
| 165 | nucleotide salvage (GO:0043173) | 2.33920568 |
| 166 | phosphate ion transport (GO:0006817) | 2.33704737 |
| 167 | one-carbon metabolic process (GO:0006730) | 2.33333381 |
| 168 | regulation of gene silencing (GO:0060968) | 2.33044150 |
| 169 | nuclear pore complex assembly (GO:0051292) | 2.31150803 |
| 170 | desmosome organization (GO:0002934) | 2.31115980 |
| 171 | aromatic amino acid family catabolic process (GO:0009074) | 2.30606157 |
| 172 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.30525736 |
| 173 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.30525736 |
| 174 | tight junction assembly (GO:0070830) | 2.29764686 |
| 175 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.29742917 |
| 176 | UMP biosynthetic process (GO:0006222) | 2.29742917 |
| 177 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.29742917 |
| 178 | UMP metabolic process (GO:0046049) | 2.29742917 |
| 179 | phosphate ion transmembrane transport (GO:0035435) | 2.28609297 |
| 180 | determination of adult lifespan (GO:0008340) | 2.27951120 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.30861941 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.09773578 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.08944591 |
| 4 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.94450156 |
| 5 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.94450156 |
| 6 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.94450156 |
| 7 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.91323667 |
| 8 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.74782849 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.67153618 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.52549641 |
| 11 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.50163932 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.48353363 |
| 13 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.39470490 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.33125913 |
| 15 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.23851368 |
| 16 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.22510913 |
| 17 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.18683433 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.17363479 |
| 19 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.14631520 |
| 20 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 2.03082961 |
| 21 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.00656131 |
| 22 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.92492680 |
| 23 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.92377208 |
| 24 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.91855425 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.90247232 |
| 26 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.89337862 |
| 27 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.88703753 |
| 28 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.86998201 |
| 29 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.86446753 |
| 30 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.84692473 |
| 31 | P68_20966046_ChIP-Seq_HELA_Human | 1.83321699 |
| 32 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.83094620 |
| 33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.82403076 |
| 34 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.82166485 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.80349554 |
| 36 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.78497484 |
| 37 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.78090095 |
| 38 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.77010127 |
| 39 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.73320150 |
| 40 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.73183364 |
| 41 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69163956 |
| 42 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.67255031 |
| 43 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.64555731 |
| 44 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.64162282 |
| 45 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.62387141 |
| 46 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.62120556 |
| 47 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.60970734 |
| 48 | MYC_22102868_ChIP-Seq_BL_Human | 1.58357768 |
| 49 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.56458341 |
| 50 | KDM2B_26808549_Chip-Seq_K562_Human | 1.55049317 |
| 51 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.52574862 |
| 52 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.50322801 |
| 53 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.49884187 |
| 54 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.49488403 |
| 55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.49008095 |
| 56 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.47536632 |
| 57 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.44901940 |
| 58 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.44363123 |
| 59 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.43818013 |
| 60 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.43084973 |
| 61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.42927902 |
| 62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.42265091 |
| 63 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.41978814 |
| 64 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40666442 |
| 65 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.38982987 |
| 66 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.38567420 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.37538003 |
| 68 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.37312350 |
| 69 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.37250745 |
| 70 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.36073733 |
| 71 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.36053056 |
| 72 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.35954404 |
| 73 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.35414956 |
| 74 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34858572 |
| 75 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.34796667 |
| 76 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.34279100 |
| 77 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.34072326 |
| 78 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.33641066 |
| 79 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.33164675 |
| 80 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.33050316 |
| 81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32836234 |
| 82 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.30845520 |
| 83 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30638586 |
| 84 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.30571229 |
| 85 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.30558312 |
| 86 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30502053 |
| 87 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.29095485 |
| 88 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.29040778 |
| 89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28715717 |
| 90 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.28518054 |
| 91 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.27750786 |
| 92 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.27734875 |
| 93 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.27625733 |
| 94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.26597309 |
| 95 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.25379717 |
| 96 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.25025585 |
| 97 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.25001957 |
| 98 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.23819856 |
| 99 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.23240314 |
| 100 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.21690085 |
| 101 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21653452 |
| 102 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21582154 |
| 103 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.21475407 |
| 104 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.21359875 |
| 105 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20786024 |
| 106 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.20287348 |
| 107 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.19631501 |
| 108 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.19209868 |
| 109 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18692159 |
| 110 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.18254319 |
| 111 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.16062286 |
| 112 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15651888 |
| 113 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15175045 |
| 114 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.15116209 |
| 115 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.14985227 |
| 116 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.14581597 |
| 117 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.13726179 |
| 118 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.13047381 |
| 119 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.13022243 |
| 120 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 1.12631361 |
| 121 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.12565235 |
| 122 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.12378600 |
| 123 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.11676852 |
| 124 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.11220934 |
| 125 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.10337185 |
| 126 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.09591800 |
| 127 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08038771 |
| 128 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.07519288 |
| 129 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.06484977 |
| 130 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.06463436 |
| 131 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05481427 |
| 132 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04769979 |
| 133 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.04163600 |
| 134 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.04099003 |
| 135 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03883137 |
| 136 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03416873 |
| 137 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.03162668 |
| 138 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02049687 |
| 139 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.00785248 |
| 140 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.00104091 |
| 141 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.99141043 |
| 142 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.97449786 |
| 143 | SA1_27219007_Chip-Seq_Bcells_Human | 0.97080837 |
| 144 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97077127 |
| 145 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96667874 |
| 146 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95913841 |
| 147 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95723792 |
| 148 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95529762 |
| 149 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.95350386 |
| 150 | * TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.93992108 |
| 151 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93980637 |
| 152 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.93893816 |
| 153 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93228878 |
| 154 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92971894 |
| 155 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92943970 |
| 156 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92662530 |
| 157 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.92606249 |
| 158 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92439749 |
| 159 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.92054794 |
| 160 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90126824 |
| 161 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.88693367 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 4.13714281 |
| 2 | MP0004264_abnormal_extraembryonic_tissu | 3.88228111 |
| 3 | MP0005360_urolithiasis | 3.47163529 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.23019794 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.01366954 |
| 6 | MP0005365_abnormal_bile_salt | 2.91016942 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 2.69706360 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 2.61586513 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.60403156 |
| 10 | MP0000566_synostosis | 2.59086817 |
| 11 | MP0003283_abnormal_digestive_organ | 2.44262817 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.33797353 |
| 13 | MP0003693_abnormal_embryo_hatching | 2.27688161 |
| 14 | MP0001873_stomach_inflammation | 2.24238215 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.23933612 |
| 16 | MP0004957_abnormal_blastocyst_morpholog | 2.22110508 |
| 17 | MP0003252_abnormal_bile_duct | 2.10121227 |
| 18 | MP0000383_abnormal_hair_follicle | 2.06625756 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.05121359 |
| 20 | MP0009840_abnormal_foam_cell | 2.04097752 |
| 21 | MP0002249_abnormal_larynx_morphology | 2.00958125 |
| 22 | MP0002653_abnormal_ependyma_morphology | 1.96622727 |
| 23 | MP0005409_darkened_coat_color | 1.94615352 |
| 24 | MP0003183_abnormal_peptide_metabolism | 1.89267610 |
| 25 | MP0004381_abnormal_hair_follicle | 1.83538599 |
| 26 | MP0002796_impaired_skin_barrier | 1.82962244 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 1.82909384 |
| 28 | MP0004782_abnormal_surfactant_physiolog | 1.82192423 |
| 29 | MP0003119_abnormal_digestive_system | 1.71183780 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.70398995 |
| 31 | MP0003866_abnormal_defecation | 1.67791835 |
| 32 | MP0001664_abnormal_digestion | 1.64377346 |
| 33 | MP0008875_abnormal_xenobiotic_pharmacok | 1.62789291 |
| 34 | MP0004858_abnormal_nervous_system | 1.59992785 |
| 35 | MP0005083_abnormal_biliary_tract | 1.57072667 |
| 36 | MP0001765_abnormal_ion_homeostasis | 1.55686015 |
| 37 | MP0002089_abnormal_postnatal_growth/wei | 1.53504084 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.52551767 |
| 39 | MP0005332_abnormal_amino_acid | 1.52373342 |
| 40 | MP0003566_abnormal_cell_adhesion | 1.52357690 |
| 41 | MP0004043_abnormal_pH_regulation | 1.51108224 |
| 42 | MP0005076_abnormal_cell_differentiation | 1.49745101 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.49658722 |
| 44 | MP0001730_embryonic_growth_arrest | 1.49477426 |
| 45 | MP0000537_abnormal_urethra_morphology | 1.46260971 |
| 46 | MP0001849_ear_inflammation | 1.43575685 |
| 47 | MP0000462_abnormal_digestive_system | 1.43411236 |
| 48 | MP0008872_abnormal_physiological_respon | 1.42829444 |
| 49 | MP0000579_abnormal_nail_morphology | 1.42506959 |
| 50 | MP0003941_abnormal_skin_development | 1.40272620 |
| 51 | MP0002086_abnormal_extraembryonic_tissu | 1.40268267 |
| 52 | MP0008260_abnormal_autophagy | 1.38604050 |
| 53 | MP0005220_abnormal_exocrine_pancreas | 1.36386008 |
| 54 | MP0003111_abnormal_nucleus_morphology | 1.35127516 |
| 55 | MP0002254_reproductive_system_inflammat | 1.34943216 |
| 56 | MP0001672_abnormal_embryogenesis/_devel | 1.34434363 |
| 57 | MP0005380_embryogenesis_phenotype | 1.34434363 |
| 58 | MP0003879_abnormal_hair_cell | 1.34133445 |
| 59 | MP0010155_abnormal_intestine_physiology | 1.33070353 |
| 60 | MP0002877_abnormal_melanocyte_morpholog | 1.32492100 |
| 61 | MP0002084_abnormal_developmental_patter | 1.29158946 |
| 62 | MP0003890_abnormal_embryonic-extraembry | 1.29080438 |
| 63 | MP0005501_abnormal_skin_physiology | 1.25534871 |
| 64 | MP0003453_abnormal_keratinocyte_physiol | 1.22805223 |
| 65 | MP0003984_embryonic_growth_retardation | 1.21337395 |
| 66 | MP0002088_abnormal_embryonic_growth/wei | 1.20892529 |
| 67 | MP0004133_heterotaxia | 1.20675932 |
| 68 | MP0000003_abnormal_adipose_tissue | 1.19135214 |
| 69 | MP0008057_abnormal_DNA_replication | 1.18806364 |
| 70 | MP0002085_abnormal_embryonic_tissue | 1.18156382 |
| 71 | MP0001697_abnormal_embryo_size | 1.17762241 |
| 72 | MP0003195_calcinosis | 1.17104215 |
| 73 | MP0003077_abnormal_cell_cycle | 1.16671577 |
| 74 | MP0002132_abnormal_respiratory_system | 1.16588592 |
| 75 | MP0010329_abnormal_lipoprotein_level | 1.15872308 |
| 76 | MP0004197_abnormal_fetal_growth/weight/ | 1.14181901 |
| 77 | MP0004185_abnormal_adipocyte_glucose | 1.12705635 |
| 78 | MP0000538_abnormal_urinary_bladder | 1.11958896 |
| 79 | MP0010030_abnormal_orbit_morphology | 1.11549004 |
| 80 | MP0000609_abnormal_liver_physiology | 1.11282815 |
| 81 | MP0003878_abnormal_ear_physiology | 1.10274130 |
| 82 | MP0005377_hearing/vestibular/ear_phenot | 1.10274130 |
| 83 | MP0000490_abnormal_crypts_of | 1.07708693 |
| 84 | MP0004947_skin_inflammation | 1.05848093 |
| 85 | MP0000350_abnormal_cell_proliferation | 1.04207946 |
| 86 | MP0000678_abnormal_parathyroid_gland | 1.03818827 |
| 87 | MP0000627_abnormal_mammary_gland | 1.01978682 |
| 88 | MP0000477_abnormal_intestine_morphology | 1.01143229 |
| 89 | MP0005023_abnormal_wound_healing | 0.99899092 |
| 90 | MP0002080_prenatal_lethality | 0.99432747 |
| 91 | MP0009931_abnormal_skin_appearance | 0.96968748 |
| 92 | MP0002166_altered_tumor_susceptibility | 0.96042947 |
| 93 | MP0005636_abnormal_mineral_homeostasis | 0.93543212 |
| 94 | MP0001756_abnormal_urination | 0.93287461 |
| 95 | MP0002909_abnormal_adrenal_gland | 0.93275878 |
| 96 | MP0009053_abnormal_anal_canal | 0.92611589 |
| 97 | MP0003718_maternal_effect | 0.92316478 |
| 98 | MP0002098_abnormal_vibrissa_morphology | 0.91747557 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.90875155 |
| 100 | MP0010771_integument_phenotype | 0.90559255 |
| 101 | MP0010094_abnormal_chromosome_stability | 0.90058423 |
| 102 | MP0003123_paternal_imprinting | 0.89272150 |
| 103 | MP0002060_abnormal_skin_morphology | 0.87826317 |
| 104 | MP0001881_abnormal_mammary_gland | 0.87074292 |
| 105 | MP0005375_adipose_tissue_phenotype | 0.86935461 |
| 106 | MP0003638_abnormal_response/metabolism_ | 0.85806521 |
| 107 | MP0000858_altered_metastatic_potential | 0.85447181 |
| 108 | MP0000013_abnormal_adipose_tissue | 0.83131593 |
| 109 | MP0001944_abnormal_pancreas_morphology | 0.82430782 |
| 110 | MP0003191_abnormal_cellular_cholesterol | 0.82118486 |
| 111 | MP0003938_abnormal_ear_development | 0.81582086 |
| 112 | MP0005381_digestive/alimentary_phenotyp | 0.81463113 |
| 113 | MP0005670_abnormal_white_adipose | 0.80632038 |
| 114 | MP0005266_abnormal_metabolism | 0.80443954 |
| 115 | MP0009384_cardiac_valve_regurgitation | 0.80326590 |
| 116 | MP0003868_abnormal_feces_composition | 0.79194266 |
| 117 | MP0001293_anophthalmia | 0.79114269 |
| 118 | MP0010678_abnormal_skin_adnexa | 0.79074607 |
| 119 | MP0000598_abnormal_liver_morphology | 0.78484335 |
| 120 | MP0000427_abnormal_hair_cycle | 0.78467756 |
| 121 | MP0003567_abnormal_fetal_cardiomyocyte | 0.78447563 |
| 122 | MP0001216_abnormal_epidermal_layer | 0.78431181 |
| 123 | MP0002136_abnormal_kidney_physiology | 0.78026821 |
| 124 | MP0000467_abnormal_esophagus_morphology | 0.75654553 |
| 125 | MP0010307_abnormal_tumor_latency | 0.74865194 |
| 126 | MP0003300_gastrointestinal_ulcer | 0.74101443 |
| 127 | MP0002118_abnormal_lipid_homeostasis | 0.73066285 |
| 128 | MP0002111_abnormal_tail_morphology | 0.71458821 |
| 129 | MP0001663_abnormal_digestive_system | 0.71008740 |
| 130 | MP0002269_muscular_atrophy | 0.70548438 |
| 131 | MP0000367_abnormal_coat/_hair | 0.69889706 |
| 132 | MP0000470_abnormal_stomach_morphology | 0.69452838 |
| 133 | MP0002822_catalepsy | 0.69246700 |
| 134 | MP0008932_abnormal_embryonic_tissue | 0.68189736 |
| 135 | MP0002928_abnormal_bile_duct | 0.68133249 |
| 136 | MP0009672_abnormal_birth_weight | 0.67780969 |
| 137 | MP0005451_abnormal_body_composition | 0.67663120 |
| 138 | MP0000613_abnormal_salivary_gland | 0.67161678 |
| 139 | MP0002697_abnormal_eye_size | 0.66549751 |
| 140 | MP0001764_abnormal_homeostasis | 0.65513314 |
| 141 | MP0000377_abnormal_hair_follicle | 0.65039864 |
| 142 | MP0002693_abnormal_pancreas_physiology | 0.64285742 |
| 143 | MP0006072_abnormal_retinal_apoptosis | 0.64251075 |
| 144 | MP0000516_abnormal_urinary_system | 0.64150452 |
| 145 | MP0005367_renal/urinary_system_phenotyp | 0.64150452 |
| 146 | MP0002970_abnormal_white_adipose | 0.63909416 |
| 147 | MP0005666_abnormal_adipose_tissue | 0.63879728 |
| 148 | MP0003936_abnormal_reproductive_system | 0.63766677 |
| 149 | MP0003115_abnormal_respiratory_system | 0.62414957 |
| 150 | MP0002277_abnormal_respiratory_mucosa | 0.59857083 |
| 151 | MP0009379_abnormal_foot_pigmentation | 0.59462403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | J-shaped sella turcica (HP:0002680) | 5.17114465 |
| 2 | Gout (HP:0001997) | 4.04660608 |
| 3 | Thin bony cortex (HP:0002753) | 3.97077996 |
| 4 | Hypoglycemic coma (HP:0001325) | 3.82675456 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.74240891 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 3.67729479 |
| 7 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.62799459 |
| 8 | Lymphangioma (HP:0100764) | 3.58311460 |
| 9 | Hyperglycinuria (HP:0003108) | 3.56952467 |
| 10 | Ependymoma (HP:0002888) | 3.33862357 |
| 11 | Amelogenesis imperfecta (HP:0000705) | 3.31028356 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 3.21068590 |
| 13 | Septate vagina (HP:0001153) | 3.17577028 |
| 14 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.15955296 |
| 15 | Malnutrition (HP:0004395) | 3.11920205 |
| 16 | Hemorrhage of the eye (HP:0011885) | 3.09169160 |
| 17 | Hypoglycemic seizures (HP:0002173) | 3.06022360 |
| 18 | Asymmetry of the thorax (HP:0001555) | 3.05252629 |
| 19 | Stridor (HP:0010307) | 3.04506746 |
| 20 | Broad face (HP:0000283) | 3.03400928 |
| 21 | Ketoacidosis (HP:0001993) | 2.93681365 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.92441426 |
| 23 | Bronchomalacia (HP:0002780) | 2.83501897 |
| 24 | Late onset (HP:0003584) | 2.81856954 |
| 25 | Decreased circulating renin level (HP:0003351) | 2.77461897 |
| 26 | Germ cell neoplasia (HP:0100728) | 2.76010749 |
| 27 | Hyperactive renin-angiotensin system (HP:0000841) | 2.74987203 |
| 28 | Pili torti (HP:0003777) | 2.74977287 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 2.72824974 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.72824974 |
| 31 | Visceral angiomatosis (HP:0100761) | 2.70440838 |
| 32 | Esophageal varix (HP:0002040) | 2.68704604 |
| 33 | Shawl scrotum (HP:0000049) | 2.68150969 |
| 34 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.67093446 |
| 35 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.67093446 |
| 36 | Vertebral clefting (HP:0008428) | 2.65050529 |
| 37 | Hyperglycinemia (HP:0002154) | 2.64767686 |
| 38 | Hyperacusis (HP:0010780) | 2.64137107 |
| 39 | Short humerus (HP:0005792) | 2.61307469 |
| 40 | Hypobetalipoproteinemia (HP:0003563) | 2.57668579 |
| 41 | Xanthomatosis (HP:0000991) | 2.55358690 |
| 42 | Abnormality of renin-angiotensin system (HP:0000847) | 2.54560307 |
| 43 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.53365987 |
| 44 | Abnormality of purine metabolism (HP:0004352) | 2.53313899 |
| 45 | Cerebral aneurysm (HP:0004944) | 2.52107446 |
| 46 | Ketosis (HP:0001946) | 2.51610676 |
| 47 | Deformed sella turcica (HP:0002681) | 2.50656131 |
| 48 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.50236971 |
| 49 | Biliary tract neoplasm (HP:0100574) | 2.50043330 |
| 50 | Cervical subluxation (HP:0003308) | 2.46079368 |
| 51 | Diaphragmatic weakness (HP:0009113) | 2.45940905 |
| 52 | Hyperammonemia (HP:0001987) | 2.45170702 |
| 53 | Hemangiomatosis (HP:0007461) | 2.44699496 |
| 54 | Increased purine levels (HP:0004368) | 2.43368071 |
| 55 | Hyperuricemia (HP:0002149) | 2.43368071 |
| 56 | Abnormality of nucleobase metabolism (HP:0010932) | 2.42552440 |
| 57 | Symptomatic seizures (HP:0011145) | 2.42518869 |
| 58 | Multiple enchondromatosis (HP:0005701) | 2.38600724 |
| 59 | Hyperglycemia (HP:0003074) | 2.38099113 |
| 60 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.36891109 |
| 61 | Metaphyseal cupping (HP:0003021) | 2.33521341 |
| 62 | Missing ribs (HP:0000921) | 2.31494852 |
| 63 | Spastic diplegia (HP:0001264) | 2.30699791 |
| 64 | Spinal cord compression (HP:0002176) | 2.29968593 |
| 65 | Abnormal biliary tract morphology (HP:0012440) | 2.29322115 |
| 66 | Abnormality of chloride homeostasis (HP:0011422) | 2.27574180 |
| 67 | Mucopolysacchariduria (HP:0008155) | 2.26866302 |
| 68 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.26866302 |
| 69 | Distal lower limb muscle weakness (HP:0009053) | 2.26408798 |
| 70 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.26402949 |
| 71 | Flattened epiphyses (HP:0003071) | 2.23558474 |
| 72 | Hyperparathyroidism (HP:0000843) | 2.22075801 |
| 73 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.21029524 |
| 74 | Rib fusion (HP:0000902) | 2.20472037 |
| 75 | Distal upper limb amyotrophy (HP:0007149) | 2.19910048 |
| 76 | Upper limb amyotrophy (HP:0009129) | 2.19910048 |
| 77 | Fat malabsorption (HP:0002630) | 2.19675078 |
| 78 | Abnormal vertebral ossification (HP:0100569) | 2.19036537 |
| 79 | Abdominal distention (HP:0003270) | 2.18061932 |
| 80 | Hypophosphatemia (HP:0002148) | 2.17189534 |
| 81 | Abnormality of the salivary glands (HP:0010286) | 2.15815155 |
| 82 | Concave nail (HP:0001598) | 2.14965488 |
| 83 | Focal segmental glomerulosclerosis (HP:0000097) | 2.14804760 |
| 84 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.14161404 |
| 85 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.14161404 |
| 86 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.14161404 |
| 87 | Unilateral renal agenesis (HP:0000122) | 2.13800240 |
| 88 | Renal salt wasting (HP:0000127) | 2.13583686 |
| 89 | Ileus (HP:0002595) | 2.13218361 |
| 90 | Enlarged penis (HP:0000040) | 2.11115931 |
| 91 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.10325439 |
| 92 | Abnormality of the astrocytes (HP:0100707) | 2.09456831 |
| 93 | Astrocytoma (HP:0009592) | 2.09456831 |
| 94 | Curly hair (HP:0002212) | 2.08224933 |
| 95 | Abnormal cartilage morphology (HP:0002763) | 2.04660204 |
| 96 | Flat acetabular roof (HP:0003180) | 2.04328554 |
| 97 | Insulin resistance (HP:0000855) | 2.03141200 |
| 98 | Lip pit (HP:0100267) | 2.01954210 |
| 99 | Seborrheic dermatitis (HP:0001051) | 2.00290177 |
| 100 | Alkalosis (HP:0001948) | 1.99875822 |
| 101 | Abnormality of the gastric mucosa (HP:0004295) | 1.99838838 |
| 102 | Proximal tubulopathy (HP:0000114) | 1.99057776 |
| 103 | Hand muscle atrophy (HP:0009130) | 1.98455444 |
| 104 | Chronic bronchitis (HP:0004469) | 1.98431990 |
| 105 | Breast carcinoma (HP:0003002) | 1.98040616 |
| 106 | Easy fatigability (HP:0003388) | 1.96907135 |
| 107 | Obstructive sleep apnea (HP:0002870) | 1.96270216 |
| 108 | Hypolipoproteinemia (HP:0010981) | 1.95069577 |
| 109 | Abnormal hair laboratory examination (HP:0003328) | 1.94988428 |
| 110 | Deep venous thrombosis (HP:0002625) | 1.94437752 |
| 111 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.94113090 |
| 112 | Abnormal pancreas size (HP:0012094) | 1.93392763 |
| 113 | Rhabdomyosarcoma (HP:0002859) | 1.93037050 |
| 114 | Distal lower limb amyotrophy (HP:0008944) | 1.92975582 |
| 115 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.91374261 |
| 116 | Abnormality of the intrinsic pathway (HP:0010989) | 1.87529595 |
| 117 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.86803593 |
| 118 | Vertebral hypoplasia (HP:0008417) | 1.86803593 |
| 119 | Growth hormone excess (HP:0000845) | 1.86409614 |
| 120 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.86355985 |
| 121 | Villous atrophy (HP:0011473) | 1.86355985 |
| 122 | Hyperphosphatemia (HP:0002905) | 1.85761964 |
| 123 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.84582608 |
| 124 | Selective tooth agenesis (HP:0001592) | 1.83963359 |
| 125 | Absent radius (HP:0003974) | 1.83629064 |
| 126 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.82424037 |
| 127 | Gastrointestinal carcinoma (HP:0002672) | 1.82424037 |
| 128 | Advanced eruption of teeth (HP:0006288) | 1.82229242 |
| 129 | Bell-shaped thorax (HP:0001591) | 1.80445151 |
| 130 | Back pain (HP:0003418) | 1.80439091 |
| 131 | Pseudobulbar signs (HP:0002200) | 1.80011800 |
| 132 | Widely patent fontanelles and sutures (HP:0004492) | 1.79744537 |
| 133 | Irritability (HP:0000737) | 1.79742785 |
| 134 | Trismus (HP:0000211) | 1.79185273 |
| 135 | Protuberant abdomen (HP:0001538) | 1.79135078 |
| 136 | Nuclear cataract (HP:0100018) | 1.78941603 |
| 137 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.78919218 |
| 138 | Dysostosis multiplex (HP:0000943) | 1.78867518 |
| 139 | Fused cervical vertebrae (HP:0002949) | 1.77504989 |
| 140 | Posterior subcapsular cataract (HP:0007787) | 1.77169691 |
| 141 | Hydroxyprolinuria (HP:0003080) | 1.77044992 |
| 142 | Abnormality of proline metabolism (HP:0010907) | 1.77044992 |
| 143 | Breast hypoplasia (HP:0003187) | 1.75637612 |
| 144 | Pterygium (HP:0001059) | 1.74953725 |
| 145 | Glomerulonephritis (HP:0000099) | 1.74697964 |
| 146 | Neoplasm of the oral cavity (HP:0100649) | 1.74494468 |
| 147 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.74217952 |
| 148 | Hyponatremia (HP:0002902) | 1.73545215 |
| 149 | Sparse lateral eyebrow (HP:0005338) | 1.72762723 |
| 150 | Nasal polyposis (HP:0100582) | 1.71944778 |
| 151 | Abnormality of the thoracic spine (HP:0100711) | 1.71778049 |
| 152 | Aplasia involving forearm bones (HP:0009822) | 1.71735235 |
| 153 | Absent forearm bone (HP:0003953) | 1.71735235 |
| 154 | Micronodular cirrhosis (HP:0001413) | 1.71621007 |
| 155 | Vascular calcification (HP:0004934) | 1.70858789 |
| 156 | Interstitial pulmonary disease (HP:0006530) | 1.70612305 |
| 157 | Uterine neoplasm (HP:0010784) | 1.70531737 |
| 158 | Congenital glaucoma (HP:0001087) | 1.70231824 |
| 159 | Woolly hair (HP:0002224) | 1.69787381 |
| 160 | Abnormal tarsal ossification (HP:0008369) | 1.69369183 |
| 161 | Hypotension (HP:0002615) | 1.69154732 |
| 162 | Neoplasm of striated muscle (HP:0009728) | 1.69037362 |
| 163 | Testicular neoplasm (HP:0010788) | 1.68628099 |
| 164 | Abnormality of the dental root (HP:0006486) | 1.68444531 |
| 165 | Taurodontia (HP:0000679) | 1.68444531 |
| 166 | Abnormality of permanent molar morphology (HP:0011071) | 1.68444531 |
| 167 | Increased cerebral lipofuscin (HP:0011813) | 1.68443981 |
| 168 | Renal tubular acidosis (HP:0001947) | 1.67586913 |
| 169 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.66361335 |
| 170 | Glomerulosclerosis (HP:0000096) | 1.66113097 |
| 171 | Abnormal hemoglobin (HP:0011902) | 1.66103614 |
| 172 | Neonatal death (HP:0003811) | 1.65460101 |
| 173 | Abnormality of the 1st metacarpal (HP:0010009) | 1.65202795 |
| 174 | Turricephaly (HP:0000262) | 1.65032111 |
| 175 | Generalized aminoaciduria (HP:0002909) | 1.64546062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 5.19828075 |
| 2 | CDK12 | 3.63215511 |
| 3 | SMG1 | 2.49989710 |
| 4 | RPS6KB2 | 2.45151328 |
| 5 | LATS1 | 2.37903098 |
| 6 | ERN1 | 2.28841636 |
| 7 | MAPK15 | 2.17732778 |
| 8 | STK38L | 2.17358867 |
| 9 | TTK | 2.05576920 |
| 10 | BCKDK | 2.03474369 |
| 11 | NME1 | 1.97726476 |
| 12 | NME2 | 1.96915068 |
| 13 | MAP3K10 | 1.92405766 |
| 14 | AKT3 | 1.86214657 |
| 15 | RIPK1 | 1.82662518 |
| 16 | MAP2K2 | 1.82458650 |
| 17 | MAPKAPK3 | 1.80998347 |
| 18 | TRIB3 | 1.76579778 |
| 19 | PASK | 1.73146481 |
| 20 | NEK1 | 1.72824685 |
| 21 | PKN2 | 1.72319571 |
| 22 | PIK3CA | 1.69392341 |
| 23 | WNK3 | 1.64885490 |
| 24 | ICK | 1.63930453 |
| 25 | NEK2 | 1.61225830 |
| 26 | MUSK | 1.57710150 |
| 27 | STK10 | 1.52858527 |
| 28 | FLT3 | 1.49600165 |
| 29 | MET | 1.49307867 |
| 30 | PTK2 | 1.48361910 |
| 31 | DDR2 | 1.44580642 |
| 32 | EEF2K | 1.39702160 |
| 33 | PAK4 | 1.37447055 |
| 34 | LMTK2 | 1.37044534 |
| 35 | PTK6 | 1.32710910 |
| 36 | CDK7 | 1.30722948 |
| 37 | MST4 | 1.27508932 |
| 38 | MAP2K6 | 1.26098681 |
| 39 | MTOR | 1.24348061 |
| 40 | IRAK3 | 1.16310719 |
| 41 | SCYL2 | 1.15963312 |
| 42 | MAP3K8 | 1.15901320 |
| 43 | PDGFRA | 1.14695114 |
| 44 | WEE1 | 1.14425536 |
| 45 | MAP3K3 | 1.13788376 |
| 46 | FGFR4 | 1.12420099 |
| 47 | FRK | 1.12145453 |
| 48 | NEK6 | 1.10856133 |
| 49 | WNK4 | 1.07877634 |
| 50 | INSRR | 1.06583219 |
| 51 | LATS2 | 1.05673805 |
| 52 | ERBB2 | 1.04994378 |
| 53 | TNK2 | 1.04717069 |
| 54 | BUB1 | 1.01314681 |
| 55 | GRK6 | 1.00563057 |
| 56 | SIK1 | 0.98350702 |
| 57 | TAOK3 | 0.97913414 |
| 58 | DYRK1B | 0.97723032 |
| 59 | BRD4 | 0.97441596 |
| 60 | MAP3K11 | 0.94235035 |
| 61 | RPS6KA2 | 0.92958195 |
| 62 | PDPK1 | 0.92789337 |
| 63 | STK39 | 0.91276725 |
| 64 | PLK1 | 0.91181698 |
| 65 | DYRK3 | 0.86726204 |
| 66 | AURKB | 0.86591942 |
| 67 | CDK4 | 0.85978618 |
| 68 | FGFR2 | 0.85105433 |
| 69 | ERBB4 | 0.84036366 |
| 70 | CHEK2 | 0.82792472 |
| 71 | TBK1 | 0.77436589 |
| 72 | TAOK1 | 0.76312787 |
| 73 | EPHB1 | 0.76041679 |
| 74 | CDK6 | 0.75611659 |
| 75 | MST1R | 0.74749384 |
| 76 | PLK4 | 0.73034398 |
| 77 | BMX | 0.72844185 |
| 78 | PRKG2 | 0.72599918 |
| 79 | MARK2 | 0.71670084 |
| 80 | SIK3 | 0.71652821 |
| 81 | FER | 0.71403844 |
| 82 | LRRK2 | 0.71371312 |
| 83 | CDC7 | 0.70979484 |
| 84 | STK3 | 0.70880803 |
| 85 | PIM1 | 0.70057186 |
| 86 | TYRO3 | 0.68704953 |
| 87 | RET | 0.68325733 |
| 88 | MAP3K2 | 0.64954425 |
| 89 | MAPK11 | 0.64818416 |
| 90 | RPS6KL1 | 0.62627174 |
| 91 | RPS6KC1 | 0.62627174 |
| 92 | MATK | 0.62340422 |
| 93 | CHEK1 | 0.61922075 |
| 94 | GSK3A | 0.60516628 |
| 95 | ILK | 0.60306371 |
| 96 | FGFR3 | 0.59508734 |
| 97 | CSK | 0.59173771 |
| 98 | AURKA | 0.58813926 |
| 99 | ALK | 0.57804866 |
| 100 | PRKD2 | 0.56801735 |
| 101 | AKT2 | 0.54927378 |
| 102 | MAP3K6 | 0.54009873 |
| 103 | MAP3K1 | 0.53014107 |
| 104 | RPS6KA6 | 0.52968980 |
| 105 | KSR2 | 0.50333721 |
| 106 | MAP4K1 | 0.50184014 |
| 107 | MAP3K7 | 0.50071591 |
| 108 | MELK | 0.49537984 |
| 109 | MAP2K3 | 0.49397557 |
| 110 | BRSK2 | 0.49395041 |
| 111 | HIPK2 | 0.49102132 |
| 112 | PRKAA1 | 0.48306189 |
| 113 | TESK2 | 0.48205099 |
| 114 | PRKD3 | 0.46297787 |
| 115 | MAPKAPK2 | 0.45914745 |
| 116 | CDK2 | 0.45004184 |
| 117 | CHUK | 0.44786566 |
| 118 | RPS6KA4 | 0.44507339 |
| 119 | STK38 | 0.43473209 |
| 120 | CDC42BPA | 0.43134233 |
| 121 | * PRKCI | 0.41996120 |
| 122 | CSNK1E | 0.41634670 |
| 123 | PDK1 | 0.41547354 |
| 124 | TTN | 0.41384280 |
| 125 | PAK2 | 0.39428526 |
| 126 | PRKAA2 | 0.38569302 |
| 127 | TESK1 | 0.37437226 |
| 128 | MAP2K1 | 0.37303388 |
| 129 | ATR | 0.36722591 |
| 130 | ATM | 0.35801322 |
| 131 | CSF1R | 0.35749198 |
| 132 | RPS6KA1 | 0.35327123 |
| 133 | IKBKE | 0.35117203 |
| 134 | MAPK8 | 0.32553224 |
| 135 | PRKD1 | 0.29864454 |
| 136 | CAMKK1 | 0.27086900 |
| 137 | PRKCZ | 0.24783379 |
| 138 | CSNK1A1 | 0.23004500 |
| 139 | CAMK2G | 0.22278281 |
| 140 | PRPF4B | 0.22004882 |
| 141 | DAPK1 | 0.21939517 |
| 142 | TYK2 | 0.21270885 |
| 143 | IKBKB | 0.21143261 |
| 144 | CAMK2D | 0.20711245 |
| 145 | TAOK2 | 0.19163999 |
| 146 | STK24 | 0.19058208 |
| 147 | FGFR1 | 0.18082884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.82895650 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.50990025 |
| 3 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.34502209 |
| 4 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.33284792 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.26754874 |
| 6 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.18054853 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.16862236 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.09033728 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.06933084 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.01110642 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.98813837 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.95965902 |
| 13 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.92983460 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.87797164 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.79041004 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.74178506 |
| 17 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.74155081 |
| 18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.74062535 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.63602805 |
| 20 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.62493157 |
| 21 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.59567875 |
| 22 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.54877117 |
| 23 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.53896301 |
| 24 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.52865818 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.47909549 |
| 26 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.46708072 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.46288888 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.43287947 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.41715620 |
| 30 | Lysine degradation_Homo sapiens_hsa00310 | 1.38799423 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.38032349 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.36971032 |
| 33 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.35599563 |
| 34 | Hepatitis C_Homo sapiens_hsa05160 | 1.35584675 |
| 35 | Galactose metabolism_Homo sapiens_hsa00052 | 1.34843682 |
| 36 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.34123478 |
| 37 | Mismatch repair_Homo sapiens_hsa03430 | 1.32914178 |
| 38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.31225821 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.29933399 |
| 40 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.29083416 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26488816 |
| 42 | Histidine metabolism_Homo sapiens_hsa00340 | 1.23361813 |
| 43 | Endometrial cancer_Homo sapiens_hsa05213 | 1.19686835 |
| 44 | RNA transport_Homo sapiens_hsa03013 | 1.19045542 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.19010785 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.18132749 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17026716 |
| 48 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.13170324 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.12481949 |
| 50 | Bladder cancer_Homo sapiens_hsa05219 | 1.11999482 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.10197975 |
| 52 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.10173312 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.09430150 |
| 54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.07205203 |
| 55 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.02190754 |
| 56 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.00864401 |
| 57 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.99044594 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97879883 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 0.97547144 |
| 60 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.96068940 |
| 61 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.95925600 |
| 62 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.94888921 |
| 63 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.93443828 |
| 64 | Adherens junction_Homo sapiens_hsa04520 | 0.92701450 |
| 65 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.91314278 |
| 66 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.90360592 |
| 67 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.90140544 |
| 68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.89931960 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89759045 |
| 70 | DNA replication_Homo sapiens_hsa03030 | 0.89140971 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87762552 |
| 72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.87299993 |
| 73 | * Hippo signaling pathway_Homo sapiens_hsa04390 | 0.87118164 |
| 74 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86926741 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.86641761 |
| 76 | * Tight junction_Homo sapiens_hsa04530 | 0.86258360 |
| 77 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86083195 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85575680 |
| 79 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.83329552 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82452104 |
| 81 | Lysosome_Homo sapiens_hsa04142 | 0.78401062 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.78174190 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77403554 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76911565 |
| 85 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.75665785 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75264285 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.74702671 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.74267327 |
| 89 | Base excision repair_Homo sapiens_hsa03410 | 0.73707339 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.73372164 |
| 91 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73295866 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.71872292 |
| 93 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.70879368 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.70796530 |
| 95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.70493443 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.69671411 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69613753 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65706598 |
| 99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.64974021 |
| 100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63438394 |
| 101 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61330502 |
| 102 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59656519 |
| 103 | Cell cycle_Homo sapiens_hsa04110 | 0.59187535 |
| 104 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.58258570 |
| 105 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.58056657 |
| 106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57984692 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57249486 |
| 108 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56325707 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55669566 |
| 110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53964329 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.53752952 |
| 112 | Spliceosome_Homo sapiens_hsa03040 | 0.53481113 |
| 113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53274605 |
| 114 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51161024 |
| 115 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.49411486 |
| 116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49175280 |
| 117 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48770151 |
| 118 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47813407 |
| 119 | Prostate cancer_Homo sapiens_hsa05215 | 0.46759301 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45858910 |
| 121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45360647 |
| 122 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45169705 |
| 123 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.44986734 |
| 124 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.43416278 |
| 125 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42102088 |
| 126 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.40795615 |
| 127 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39854850 |
| 128 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38667181 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38374914 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.37232693 |
| 131 | Cocaine addiction_Homo sapiens_hsa05030 | 0.36620190 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36421103 |
| 133 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35815903 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34089163 |
| 135 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33995312 |
| 136 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.33591886 |
| 137 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.32799933 |
| 138 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.32681059 |
| 139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31363002 |
| 140 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30358982 |
| 141 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.29735170 |
| 142 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.28622474 |

